Identification of upstream regulators for prognostic expression signature genes in colorectal cancer
- PMID: 24006872
- PMCID: PMC3847874
- DOI: 10.1186/1752-0509-7-86
Identification of upstream regulators for prognostic expression signature genes in colorectal cancer
Abstract
Background: Gene expression signatures have been commonly used as diagnostic and prognostic markers for cancer subtyping. However, expression signatures frequently include many passengers, which are not directly related to cancer progression. Their upstream regulators such as transcription factors (TFs) may take a more critical role as drivers or master regulators to provide better clues on the underlying regulatory mechanisms and therapeutic applications.
Results: In order to identify prognostic master regulators, we took the known 85 prognostic signature genes for colorectal cancer and inferred their upstream TFs. To this end, a global transcriptional regulatory network was constructed with total >200,000 TF-target links using the ARACNE algorithm. We selected the top 10 TFs as candidate master regulators to show the highest coverage of the signature genes among the total 846 TF-target sub-networks or regulons. The selected TFs showed a comparable or slightly better prognostic performance than the original 85 signature genes in spite of greatly reduced number of marker genes from 85 to 10. Notably, these TFs were selected solely from inferred regulatory links using gene expression profiles and included many TFs regulating tumorigenic processes such as proliferation, metastasis, and differentiation.
Conclusions: Our network approach leads to the identification of the upstream transcription factors for prognostic signature genes to provide leads to their regulatory mechanisms. We demonstrate that our approach could identify upstream biomarkers for a given set of signature genes with markedly smaller size and comparable performances. The utility of our method may be expandable to other types of signatures such as diagnosis and drug response.
Figures





Similar articles
-
Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia.BMC Genomics. 2015 Nov 25;16:1002. doi: 10.1186/s12864-015-2189-6. BMC Genomics. 2015. PMID: 26606983 Free PMC article.
-
Identification of upstream regulators for synovial expression signature genes in osteoarthritis.Joint Bone Spine. 2016 Oct;83(5):545-51. doi: 10.1016/j.jbspin.2015.09.001. Epub 2016 Jan 29. Joint Bone Spine. 2016. PMID: 26832188
-
Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.Medicina (Kaunas). 2019 Jan 17;55(1):20. doi: 10.3390/medicina55010020. Medicina (Kaunas). 2019. PMID: 30658502 Free PMC article.
-
Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.Dig Dis Sci. 2020 Dec;65(12):3538-3550. doi: 10.1007/s10620-020-06064-1. Epub 2020 Jan 20. Dig Dis Sci. 2020. PMID: 31960204 Review.
-
Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis.Front Oncol. 2021 Jun 14;11:681377. doi: 10.3389/fonc.2021.681377. eCollection 2021. Front Oncol. 2021. PMID: 34195082 Free PMC article. Review.
Cited by
-
A novel statistical approach for identification of the master regulator transcription factor.BMC Bioinformatics. 2017 Feb 2;18(1):79. doi: 10.1186/s12859-017-1499-x. BMC Bioinformatics. 2017. PMID: 28148240 Free PMC article.
-
Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development.Genes (Basel). 2021 Nov 27;12(12):1901. doi: 10.3390/genes12121901. Genes (Basel). 2021. PMID: 34946850 Free PMC article.
-
MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes.Nat Commun. 2015 Nov 17;6:8878. doi: 10.1038/ncomms9878. Nat Commun. 2015. PMID: 27305450 Free PMC article.
-
Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia.BMC Genomics. 2015 Nov 25;16:1002. doi: 10.1186/s12864-015-2189-6. BMC Genomics. 2015. PMID: 26606983 Free PMC article.
-
Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.Med Sci Monit. 2019 May 27;25:3941-3956. doi: 10.12659/MSM.913727. Med Sci Monit. 2019. PMID: 31132294 Free PMC article.
References
-
- Méndez E, Lohavanichbutr P, Fan W, Houck JR, Rue TC, Doody DR, Futran ND, Upton MP, Yueh B, Zhao LP, Schwartz SM, Chen C. Can a metastatic gene expression profile outperform tumor size as a predictor of occult lymph node metastasis in oral cancer patients? Clin Cancer Res. 2011;17:2466–73. doi: 10.1158/1078-0432.CCR-10-0175. - DOI - PMC - PubMed
-
- Servant N, Bollet MA, Halfwerk H, Bleakley K, Kreike B, Jacob L, Sie D, Kerkhoven R, Hupe P, Hadhri R, Fourquet A, Bartelink H, Barillot E, Sigal-Zafrani B, Van De Vijver M. Search for a gene expression signature of breast cancer local recurrence in young women. Clin Cancer Res. 2012;45:1704–15. - PubMed
-
- Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–26. doi: 10.1056/NEJMoa041588. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous